Thor Medical ASA (LTS:0R6Y) Cash-to-Debt : 166.65 (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Thor Medical ASA Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Thor Medical ASA's cash to debt ratio for the quarter that ended in Dec. 2024 was 166.65.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Thor Medical ASA could pay off its debt using the cash in hand for the quarter that ended in Dec. 2024.

The historical rank and industry rank for Thor Medical ASA's Cash-to-Debt or its related term are showing as below:

LTS:0R6Y' s Cash-to-Debt Range Over the Past 10 Years
Min: 25.6 Med: 5303.62 Max: No Debt
Current: 166.65

During the past 13 years, Thor Medical ASA's highest Cash to Debt Ratio was No Debt. The lowest was 25.60. And the median was 5303.62.

LTS:0R6Y's Cash-to-Debt is ranked better than
79.8% of 1485 companies
in the Biotechnology industry
Industry Median: 7.49 vs LTS:0R6Y: 166.65

Thor Medical ASA Cash-to-Debt Historical Data

The historical data trend for Thor Medical ASA's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Thor Medical ASA Cash-to-Debt Chart

Thor Medical ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash-to-Debt

Get a 7-Day Free Trial

64.13

50.24

607.25

No Debt

166.65

Thor Medical ASA Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Cash-to-Debt	Get a 7-Day Free Trial															607.25	No Debt	No Debt	32.89	166.65

Competitive Comparison of Thor Medical ASA's Cash-to-Debt

For the Biotechnology subindustry, Thor Medical ASA's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thor Medical ASA's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Thor Medical ASA's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Thor Medical ASA's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

Thor Medical ASA Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Thor Medical ASA's Cash to Debt Ratio for the fiscal year that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	122.819	/	(0.437	+	0.3)
	=	166.65

Thor Medical ASA's Cash to Debt Ratio for the quarter that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	122.819	/	(0.437	+	0.3)
	=	166.65

Thor Medical ASA (LTS:0R6Y) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Thor Medical ASA Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Thor Medical ASA's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Thor Medical ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (LTS:0R6Y) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

TRMED:Norway 8NN:Germany

Address

Karenslyst Alle 9C, Oslo, NOR, 0278

Website

https://www.thormedical.no

Thor Medical ASA is a company engaged in producing and supplying of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium (Th-232). The objective of the company is to supply alpha emitters to suppliers and developers of innovative drugs targeting indications of high unmet medical need, including any medical products and equipment, and to run business related thereto or associated therewith.

Thor Medical ASA Headlines

No Headlines